2-230211574-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_080424.4(SP110):​c.668-21A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.458 in 1,472,124 control chromosomes in the GnomAD database, including 157,209 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 18682 hom., cov: 30)
Exomes 𝑓: 0.45 ( 138527 hom. )

Consequence

SP110
NM_080424.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.53
Variant links:
Genes affected
SP110 (HGNC:5401): (SP110 nuclear body protein) The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This gene is a member of the SP100/SP140 family of nuclear body proteins and encodes a leukocyte-specific nuclear body component. The protein can function as an activator of gene transcription and may serve as a nuclear hormone receptor coactivator. In addition, it has been suggested that the protein may play a role in ribosome biogenesis and in the induction of myeloid cell differentiation. Alternative splicing has been observed for this gene and three transcript variants, encoding distinct isoforms, have been identified. [provided by RefSeq, Jul 2008]
SP140 (HGNC:17133): (SP140 nuclear body protein) This gene encodes a member of the SP100 family of proteins, which are share common domains including an N-terminal homogeneously staining region domain followed by a SP100/autoimmune regulator/NucP41/P75/deformed epidermal autoregulatory factor domain, a plant homeobox zinc finger, and a bromodomain. The encoded protein is interferon-inducible and is expressed at high levels in the nuclei of leukocytes. Variants of this gene have been associated with multiple sclerosis, Crohn's disease, and chronic lymphocytic leukemia. Alternative splicing results in multiple variants. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 2-230211574-T-G is Benign according to our data. Variant chr2-230211574-T-G is described in ClinVar as [Benign]. Clinvar id is 1333151.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.687 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SP110NM_080424.4 linkc.668-21A>C intron_variant Intron 5 of 18 ENST00000258381.11 NP_536349.3 Q9HB58-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SP110ENST00000258381.11 linkc.668-21A>C intron_variant Intron 5 of 18 2 NM_080424.4 ENSP00000258381.6 Q9HB58-6

Frequencies

GnomAD3 genomes
AF:
0.489
AC:
74070
AN:
151570
Hom.:
18658
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.543
Gnomad AMI
AF:
0.429
Gnomad AMR
AF:
0.606
Gnomad ASJ
AF:
0.422
Gnomad EAS
AF:
0.707
Gnomad SAS
AF:
0.416
Gnomad FIN
AF:
0.458
Gnomad MID
AF:
0.487
Gnomad NFE
AF:
0.427
Gnomad OTH
AF:
0.497
GnomAD2 exomes
AF:
0.490
AC:
122953
AN:
250776
AF XY:
0.476
show subpopulations
Gnomad AFR exome
AF:
0.548
Gnomad AMR exome
AF:
0.697
Gnomad ASJ exome
AF:
0.406
Gnomad EAS exome
AF:
0.697
Gnomad FIN exome
AF:
0.445
Gnomad NFE exome
AF:
0.424
Gnomad OTH exome
AF:
0.471
GnomAD4 exome
AF:
0.454
AC:
600072
AN:
1320436
Hom.:
138527
Cov.:
20
AF XY:
0.450
AC XY:
299264
AN XY:
664356
show subpopulations
Gnomad4 AFR exome
AF:
0.551
AC:
17006
AN:
30846
Gnomad4 AMR exome
AF:
0.683
AC:
30421
AN:
44532
Gnomad4 ASJ exome
AF:
0.417
AC:
10524
AN:
25258
Gnomad4 EAS exome
AF:
0.697
AC:
27262
AN:
39112
Gnomad4 SAS exome
AF:
0.419
AC:
34934
AN:
83344
Gnomad4 FIN exome
AF:
0.441
AC:
23480
AN:
53274
Gnomad4 NFE exome
AF:
0.436
AC:
428368
AN:
982824
Gnomad4 Remaining exome
AF:
0.460
AC:
25629
AN:
55704
Heterozygous variant carriers
0
15066
30132
45198
60264
75330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
12748
25496
38244
50992
63740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.489
AC:
74136
AN:
151688
Hom.:
18682
Cov.:
30
AF XY:
0.494
AC XY:
36624
AN XY:
74080
show subpopulations
Gnomad4 AFR
AF:
0.542
AC:
0.5425
AN:
0.5425
Gnomad4 AMR
AF:
0.607
AC:
0.607316
AN:
0.607316
Gnomad4 ASJ
AF:
0.422
AC:
0.421857
AN:
0.421857
Gnomad4 EAS
AF:
0.706
AC:
0.706019
AN:
0.706019
Gnomad4 SAS
AF:
0.416
AC:
0.416112
AN:
0.416112
Gnomad4 FIN
AF:
0.458
AC:
0.458421
AN:
0.458421
Gnomad4 NFE
AF:
0.427
AC:
0.426705
AN:
0.426705
Gnomad4 OTH
AF:
0.497
AC:
0.496673
AN:
0.496673
Heterozygous variant carriers
0
1898
3797
5695
7594
9492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.457
Hom.:
7936
Bravo
AF:
0.505
Asia WGS
AF:
0.531
AC:
1848
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 88% of patients studied by a panel of primary immunodeficiencies. Number of patients: 84. Only high quality variants are reported. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hepatic veno-occlusive disease-immunodeficiency syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
11
DANN
Benign
0.88
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3820974; hg19: chr2-231076289; COSMIC: COSV51247617; COSMIC: COSV51247617; API